Sailaja Kamaraju
- Family Practice top 10%
-
- Global Cancer Incidence and Screening 8
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 6
- Cancer survivorship and care 5
-
- Breast Cancer Treatment Studies 6
-
- Estrogen and related hormone effects 8
- BRCA gene mutations in cancer 5
-
- Economic and Financial Impacts of Cancer 6
- Co-authors
- Joan NeunerPurushottam W. LaudElizabeth C. SmithRengaswamy SankaranarayananJeffrey DropeSurendra S. ShastriJohn A. CharlsonDouglas Yee
- Partner nations
- United StatesJapanLuxembourg
In The Last Decade
Sailaja Kamaraju
42 papers receiving 315 citations
Peers
Comparison fields: 5 of 66
- Family Practice 30
- Oncology 133
- Cancer Research 52
- Genetics 62
- Endocrinology, Diabetes and Metabolism 32
Countries citing papers authored by Sailaja Kamaraju
This map shows the geographic impact of Sailaja Kamaraju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sailaja Kamaraju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sailaja Kamaraju more than expected).
Fields of papers citing papers by Sailaja Kamaraju
This network shows the impact of papers produced by Sailaja Kamaraju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sailaja Kamaraju. The network helps show where Sailaja Kamaraju may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sailaja Kamaraju, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 6 | |
| 15 | Effect of HER2 Receptor Expression on CardiacEjection Fraction in Cancer Patients Treated withTrastuzumab | 2019 | 1 |
| 16 | 2019 | 8 | |
| 17 | 2017 | 10 | |
| 18 | 2015 | 40 | |
| 19 | 2004 | 43 | |
| 20 | 1999 | 24 |
About Sailaja Kamaraju
Sailaja Kamaraju is a scholar working on Family Practice, Oncology and Cancer Research, having authored 50 papers that have together received 320 indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (8 papers), Estrogen and related hormone effects (8 papers), Cancer Treatment and Pharmacology (7 papers), Economic and Financial Impacts of Cancer (6 papers), HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (6 papers), BRCA gene mutations in cancer (5 papers) and Cancer survivorship and care (5 papers). The work is most often cited by research in Family Practice (30 citations), Oncology (133 citations) and Cancer Research (52 citations). Sailaja Kamaraju has collaborated with scholars based in United States, Japan and Luxembourg. Frequent co-authors include Joan Neuner, Purushottam W. Laud, Elizabeth C. Smith, Rengaswamy Sankaranarayanan, Jeffrey Drope, Surendra S. Shastri, John A. Charlson, Douglas Yee, Xihong Zhang and Tomohiro Kabuta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.